Clinical trial

HLA-B35 Alleles and AIDS

NCT00340223

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2005-09-01

PhaseN/A

Study timeline

Study start (unknown)2005-09-01Date precision: month

Registry last updated2012-05-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV-1unresolved

AIDSunresolved

Interventions

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

ChicagoIllinois, United States3 Los AngelesCalifornia, United States1 BaltimoreMaryland, United States1 PittsburghPennsylvania, United States1 BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00340223 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.